Home » Topics » BioWorld Science

BioWorld Science
RSS

Paradigm Genetics changes name to Icoria

Aug. 19, 2004

Priority review for new 500-mg formulation of Invirase

Aug. 19, 2004

Canadian approval for Tiazac XC

Aug. 19, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

Chronic toxicity study completed for MDI-P

Aug. 19, 2004

Nabi completes milestones in StaphVAX development

Aug. 19, 2004

Chiron to produce pandemic-like influenza vaccines for NIAID testing

Aug. 19, 2004

Replidyne obtains rights to faropenem daloxate

Aug. 19, 2004

Preliminary phase II results for XMP-629

Aug. 19, 2004

Vernalis presents new antibacterial agents in a recent patent

Aug. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...